Table 5.
Chromosomeand Phenotype | Region(cM) | Empirical Pa | Nominal Pb |
1: | |||
Lymphocyte count | 200–231 | .0013 | .0018 |
CD19 | 197–228 | .0024 | .0039 |
CD4 | 227–252 | .0015 | .0057 |
CD8 | 196–222 | .00013 | .00020 |
2: | |||
Lymphocyte count | 28–54 | .0026 | .019 |
CD19 | 50–56 | .0010 | .0039 |
CD4 | 24–40 | .00028 | .00078 |
CD4:CD8 | 89 | .0013 | .006 |
3: | |||
NK | 192–199 | .0048 | .019 |
4: | |||
CD4:CD8 | 2–5 | .0027 | .012 |
CD4:CD8 | 53–79 | .00007 | .00012 |
8: | |||
Lymphocyte count | 15–18 | .0064 | .014 |
CD19 | 16–20 | .0029 | .0040 |
CD4 | 65–79 | .00005 | .0039 |
9: | |||
CD4 | 74–84 | .00083 | .0022 |
11 | |||
Lymphocyte count | 38–39 | .0052 | .012 |
12: | |||
CD19 | 149–156 | .00082 | .011 |
18: | |||
CD19 | 93–100 | .0033 | .0054 |
CD4 | 99–105 | .0028 | .0051 |
Note.— Probabilities were calculated using the SIBPAL2 W2 method.
Empirical significance levels (for P<.01) by chromosome regions, calculated using multipoint “new Haseman-Elston” weighted regression method with both age and sex in the model (Haseman and Elston 1972; Xu et al. 2000; SAGE 2001c).
Nominal significance levels, with both age and sex in the model.